Purchase Order 36C26225P1091

Award Date 4/29/25
Potential Completion Date 10/28/25
Potential Value $550K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $102,970.11 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for REAGENTS and has no set-aside designation. Roche Diagnostics has provided critical medical equipment, supplies, and services to the VA, Department of Defense, Department of Health and Human Services, and...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $394,430.35 contract is for the delivery of Roche Ventana reagents to support operations at VA medical facilities. This purchase order was not set aside for a specific business type. Roche Diagnostics has a long history of providing critical care medical equipment, supplies, and services to...
This $400,865.87 firm fixed price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, which does not have a set-aside designation, is for cost per test services. Roche Diagnostics has a history of providing critical care analyzers, reagents, test kits, and other laboratory equipment and supplies to...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The $119,519.52 firm fixed-price purchase order is for the delivery of reagents and consumables to support the VA's clinical laboratory operations. The contract does not have a set-aside designation. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory...
This is a $77,697.56 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract is for the supply of reagents, with no set-aside designation. Roche Diagnostics has held numerous federal contracts and subcontracts to provide medical equipment, supplies, and services across various government agencies, including the VA, Department of...
This is a $169,400.44 firm fixed-price purchase order contract awarded to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is with the Department of Veterans Affairs' Veterans Integrated Service Network 22 and does not have a set-aside designation. Through this award, Roche Diagnostics will provide reagents to support medical testing and laboratory operations at VA facilities. Roche Diagnostics has a history of providing...
This is a $92,104.71 firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the renewal of a lab supply test requirement, with a period of performance through May 2020. Roche Diagnostics has been awarded multiple VA, Department of Defense, and other federal agency contracts to...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $1,153,746.18 delivery order contract is for the provision of reagents under the VA's Critical Analyzers, Laboratory (FSS-66-III) General Services Administration (GSA) Schedule, with a firm fixed price pricing type. The contract, which has no...
The Department of Veterans Affairs (VA) awarded a $5,556,445.07 firm fixed-price delivery order to Roche Diagnostics Corporation for ROCHE COBAS 6800 reagents, consumables, and controls. This order was placed against Roche's Critical Analyzers, Laboratory schedule contract (FSS-66-III) with the General Services Administration (GSA). The 6-year order will support the VA's clinical laboratory testing capabilities at its facilities. Roche Diagnostics is a manufacturer and distributor of in vitro...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $133,694.18 firm fixed-price purchase order to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The award is for the delivery of reagents to support the VA's healthcare services for veterans, with a performance period ending on November 4, 2022. Roche Diagnostics has a history of providing critical care analyzers, reagents, test kits, and associated...

This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, and laboratory instruments. The contract, valued at $549,716.91, is for the delivery of reagents and consumables to support the VA's clinical testing and laboratory operations. This award is part of Roche's existing contract vehicles with the VA, including a $37 million Blanket Purchase Agreement for immunochemistry and clinical chemistry testing, as well as several Indefinite Delivery Contracts valued between $389,666 and $2 million. These contract vehicles are primarily established under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) and In Vitro Diagnostics, Reagents, Test (FSS-65-VII) schedules, which allow the VA and other federal agencies to efficiently acquire Roche's specialized medical diagnostic technologies through pre-negotiated pricing and terms. The contract does not have a set-aside designation, indicating Roche Diagnostics competed openly in the federal marketplace.

Generated 7/1/25, 6:40 AM